Cardinal Health Inc. recalls RECOMBINATE
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
- Products
-
- RECOMBINATE
- Company
- Cardinal Health Inc.
- Where it was sold
-
Nationwide Within the U.S.
Nationwide
- Units affected
- 3 units
- About this recall
- RECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01